These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16978694)

  • 21. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
    Telek B; Batár P; Uvardy M
    Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing the way we think about chronic lymphocytic leukemia.
    Lin TS; Grever MR; Byrd JC
    J Clin Oncol; 2005 Jun; 23(18):4009-12. PubMed ID: 15767640
    [No Abstract]   [Full Text] [Related]  

  • 23. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
    Eichhorst BF; Busch R; Schweighofer C; Wendtner CM; Emmerich B; Hallek M;
    Br J Haematol; 2007 Jan; 136(1):63-72. PubMed ID: 17083342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
    MacCallum S; Groves M; Brass D; Cunningham J; Sales M; Gelly K; Tauro S
    J Clin Pathol; 2009 May; 62(5):468-70. PubMed ID: 19398596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
    Garratty G; Petz LD
    Br J Haematol; 2007 Nov; 139(4):622-3. PubMed ID: 17979948
    [No Abstract]   [Full Text] [Related]  

  • 26. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
    Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
    J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia.
    Elter T; James R; Busch R; Winkler D; Ritgen M; Böttcher S; Kahl C; Gassmann W; Stauch M; Hasan I; Staib P; Fischer K; Fink AM; Bahlo J; Bühler A; Döhner H; Wendtner CM; Stilgenbauer S; Engert A; Hallek M
    Leukemia; 2012 Dec; 26(12):2549-52. PubMed ID: 22584787
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical challenges in chronic lymphocytic leukemia.
    O'Brien S
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):22-6. PubMed ID: 9685176
    [No Abstract]   [Full Text] [Related]  

  • 29. In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
    Tam CS
    Intern Med J; 2009 Dec; 39(12):858-9. PubMed ID: 20233254
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma.
    Fabbri A; Lenoci M; Gozzetti A; Chitarrelli I; Olcese F; Raspadori D; Gobbi M; Lauria F
    Br J Haematol; 2007 Oct; 139(1):90-3. PubMed ID: 17854311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontline therapy for chronic lymphocytic leukemia: the dilemma continues.
    Nabhan C
    Clin Cancer Res; 2008 Jul; 14(13):4353. PubMed ID: 18594019
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Wierda WG; Plunkett W; Kurzrock R; O'Brien S; Wen S; Ferrajoli A; Ravandi-Kashani F; Garcia-Manero G; Estrov Z; Kipps TJ; Brown JR; Fiorentino A; Lerner S; Kantarjian HM; Keating MJ
    J Clin Oncol; 2008 Jan; 26(2):196-203. PubMed ID: 18182662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lymphocytic leukaemia--moving towards cure?
    Hillmen P
    Lancet; 2010 Oct; 376(9747):1122-4. PubMed ID: 20888976
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL).
    Chanan-Khan A; Miller KC; Takeshita K; Koryzna A; Donohue K; Bernstein ZP; Mohr A; Klippenstein D; Wallace P; Zeldis JB; Berger C; Czuczman MS
    Blood; 2005 Nov; 106(10):3348-52. PubMed ID: 16051743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
    Tsukasaki K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
    Feugier P; Aurran T; Mahé B; Letestu R; Nguyen-Khac F; Cazin B; Tournilhac O; Maisonneuve H; Casasnovas O; Delmer A; Leblond V; Royer B; Corront B; Chevret S; Delépine R; Vaudaux S; Van Den Neste E; Béné MC; Cymbalista F; Ross-Weil D; Leprêtre S
    Haematologica; 2018 Jul; 103(7):e304-e306. PubMed ID: 29545348
    [No Abstract]   [Full Text] [Related]  

  • 37. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 38. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL
    Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract]   [Full Text] [Related]  

  • 39. Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma.
    Sacchi S; Pozzi S; Marcheselli R; Federico M; Tucci A; Merli F; Orsucci L; Liberati M; Vallisa D; Brugiatelli M;
    Cancer; 2007 Jul; 110(1):121-8. PubMed ID: 17503433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.
    Tam C; Seymour JF; Brown M; Campbell P; Scarlett J; Underhill C; Ritchie D; Bond R; Grigg AP
    Haematologica; 2005 May; 90(5):700-2. PubMed ID: 15921393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.